VEEVA-SYSTEMS-INC.
8.10.2020 13:02:10 CEST | Business Wire | Press release
Veeva Systems (NYSE: VEEV) today announced the first two applications built on the Veeva Clinical Network, the industry’s only solution that links sponsors, clinical research sites, and patients for paperless, patient-centric trials. Veeva Site Connect connects sponsors and clinical research sites to enable paperless information exchange throughout a trial. With Veeva eConsent, clinical researchers can digitize the consent process with patients and review boards, while delivering transparency to sponsors.
“Paper and manual processes are slowing trial execution and impacting the patient experience,” said Jim Reilly, vice president of Veeva Vault R&D. “By bringing together the growing community of research sites using Veeva SiteVault with the many sponsors leveraging the Veeva Vault Clinical Suite , we aim to accelerate the move to paperless and patient-centric clinical trials. Veeva Clinical Network will enable faster studies and make it easier for patients to participate in trials.”
Veeva Site Connect Now Available to Automate Information Sharing
Veeva Site Connect transforms information sharing between sites and sponsors from manual, paper-based transfers to an automated, digital exchange. By linking site operations on Veeva SiteVault to sponsor operations on Vault Clinical, key clinical trial processes are more efficient, including startup document exchange, safety letter distribution, site payment letters, and study closeout transfers. Automating information exchange improves site engagement and satisfaction, while allowing sites to focus more on patient care.
“Manually maintaining trial information and limited visibility into key study documents results in a lot of duplicate effort across sponsors and sites,” said Peter Sallstig, global head development division, senior vice president & corporate officer at Santen, a specialized company dedicated to ophthalmology with products now reaching patients in over 60 countries. “Veeva Site Connect enables us to automatically link content between Veeva Vault eTMF and Veeva SiteVault for real-time document management, more efficient collaboration, and better execution.”
Veeva Site Connect is available today, with early adopters including a top 20 pharmaceutical company, a top 10 medical device company, and a leading research hospital.
Veeva eConsent to Make Patient Participation Easier in Clinical Trials
Veeva eConsent is a free solution for sites and patients that transforms the current paper-based consent process into a digital creation, approval, and exchange process. Sites can use Veeva eConsent to tailor sponsor-provided consents to the requirements of their ethics boards. The approved consent is then delivered to a patient’s mobile device for their consent, while providing sponsors visibility throughout the process.
“The informed consent process in clinical trials has been historically paper-based and inefficient,” said Jill Janssen, director at Vanderbilt University Medical Center. “Veeva eConsent reduces complex and time-consuming paperwork to improve compliance and enhance the patient experience.”
Veeva eConsent is planned for availability in early 2021. Learn more about Veeva eConsent and Veeva Site Connect at the upcoming Veeva R&D and Quality Summit , 13-14 October, 2020. The online event is open to life sciences industry professionals. Register and stay up-to-date on program details at veeva.com/Summit .
About Veeva Systems
Veeva Systems Inc. is a leader in cloud solutions—including data, software, and services—for the global life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 900 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. The company is headquartered in the San Francisco Bay Area, with offices throughout North America, Europe, Asia, and Latin America. For more information, visit veeva.com .
Forward-looking Statements
This release contains forward-looking statements, including the market demand for and acceptance of Veeva’s products and services, the results from use of Veeva’s products and services, and general business conditions (including the on-going impact of COVID-19), particularly within the life sciences industry. Any forward-looking statements contained in this press release are based upon Veeva’s historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent Veeva’s expectations as of the date of this press announcement. Subsequent events may cause these expectations to change, and Veeva disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Additional risks and uncertainties that could affect Veeva’s financial results are included under the captions, “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” in the company’s filing on Form 10-Q for the period ended July 31, 2020. This is available on the company’s website at veeva.com under the Investors section and on the SEC’s website at sec.gov . Further information on potential risks that could affect actual results will be included in other filings Veeva makes with the SEC from time to time.
® 2020 Veeva Systems Inc. All rights reserved. Veeva and the Veeva logo are trademarks of Veeva Systems Inc.
Veeva Systems Inc. owns other registered and unregistered trademarks.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201008005437/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Blind Sailor Mitsuhiro Iwamoto Redefines the Limits of Possibility Through Technology in a Historic Trans-Pacific Project3.2.2026 04:00:00 CET | Press release
- “HIRO’s CHOICE”: A Solo, Non-Stop Crossing of the Pacific Ocean - Mitsuhiro Iwamoto, a Japanese sailor based in San Diego, who is taking on the world’s first solo, non-stop trans-Pacific crossing by a blind sailor as part of the Blind Sailor Single-Handed Pacific Crossing Project 2027, held a press conference on January 28 (local time) in San Diego, USA. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260128531637/en/ Hiro Iwamoto / Global Keynote Speaker, First Totally Blind Sailor to Cross the Pacific Project URL: https://hiros-choice.com/ On January 22 (local time), Iwamoto delivered a speech at the World Economic Forum Annual Meeting 2026 (WEF) under the theme “Sailing Through Barriers.” Speaking about the upcoming voyage, he said, “Boundaries are not decided by others. They are transcended by choice.” WEF URL: https://www.weforum.org/meetings/world-economic-forum-annual-meeting-2026/sessions/sailing-through-barriers/ D
TestMu AI (Formerly LambdaTest) Recognized in Independent Research on Autonomous Testing Platforms, Q4 20252.2.2026 18:24:00 CET | Press release
Research cites AI testing, data generation, and accelerated execution TestMu AI (formerly known as LambdaTest), the world’s first full-stack Agentic Quality Engineering platform, today announced its inclusion in The Forrester Wave™: Autonomous Testing Platforms, Q4 2025, an independent research report evaluating vendors in the autonomous testing market. The report identifies TestMu AI as a cloud-based platform for unified test orchestration and execution. It notes the platform's capabilities in cross-browser testing, real device cloud, and AI-driven automation. Specifically, the research cites TestMu AI’s testing of AI systems across dimensions, providing metrics for accuracy, intent recognition, and hallucination detection with configurable thresholds. Additionally, the report recognizes TestMu AI’s AI-powered test data generation, citing its support for Large Language Models (LLMs), multimodal inputs, and compliance-aligned workflows. The report also noted the company's strong commun
Current Chemicals Launches as Independent Specialty Materials Manufacturer, Building on 75-Year GE Legacy with Backing from Momentum Global Ventures2.2.2026 17:04:00 CET | Press release
Today marks the debut of Current Chemicals, Inc. (CCI) as a fully independent U.S.-based specialty materials manufacturer. Backed by strategic investor Momentum Global Ventures, CCI is charting a bold new path as a trusted partner for materials innovation, custom chemistry, and U.S.-based downstream manufacturing of rare earths and critical materials. The partnership between U.S.-based CCI and Netherlands-based Momentum Global Ventures reflects a strengthening transatlantic alliance at a pivotal moment for global supply chains. This partnership underscores a shared commitment to secure, reliable, and innovation-driven materials infrastructure. Originally the chemical division of GE Lighting, the team behind CCI has served as the quiet force behind groundbreaking technologies for more than 75 years, developing processes and manufacturing advanced materials for displays, lighting, energy storage, and more. As an independent company, CCI is poised to expand its impact across industries de
Laserfiche’s Taylor Grosso Honored as 2026 CRN® Channel Chief2.2.2026 16:00:00 CET | Press release
Laserfiche — the leading SaaS provider of intelligent content management — announced today that CRN® — a brand of The Channel Company — has selected Taylor Grosso, senior director, channel, Americas, as a 2026 CRN® Channel Chief. This annual recognition celebrates IT vendor and distribution executives who are shaping channel strategy and driving innovation and partnership across the industry. Grosso oversees Laserfiche’s Americas channel sales team, including the U.S., Canada, and Latin America, focusing on empowering Laserfiche Solution Providers to stay competitive as the market evolves. As more organizations seek out AI-powered tools to enhance productivity, Grosso prepares partners with the resources they need to quickly learn and sell Laserfiche’s industry-leading AI-powered document management solutions. By working closely with partners on building targeted business plans, Grosso and his team enable faster customer adoption of AI while driving revenue growth. “Over the past year,
Conga Completes Acquisition of PROS B2B Business2.2.2026 15:55:00 CET | Press release
Redefines Commercial Excellence for Enterprises with a Clear Path from Price to Signature Conga, a leader for AI-powered innovation in configure, price, quote (CPQ), contract lifecycle management (CLM), and document automation, today announced it has completed the acquisition of the B2B business of PROS Holdings, Inc (“PROS”) from certain investment funds affiliated with Thoma Bravo, the world’s largest software-focused investment firm. This transaction unites two industry leaders to help enterprises maximize revenue, reduce risk, and improve profitability. By bringing together AI-driven pricing optimization, configuration, quoting, and contracting capabilities, the combined company creates a differentiated enterprise platform that connects the commerce chain and enables end-to-end revenue orchestration from price to signature. The expanded Conga leadership team will continue to be led by CEO Dave Osborne. “To operate as connected, intelligent businesses, enterprises need a commerce ch
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom